TickerLeague

Total Debt for Revolution Medicines (RVMD)

According to Revolution Medicines's latest reported financial statements, the company's latest reported total debt is $156.63M USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$156.63M

YoY change

+16.8%

5Y CAGR

+37.2%

Peak year (2025)

$158.70M

Latest annual

$158.70M

Total Debt history chart for Revolution Medicines (RVMD) from 2017 to 2025

Total Debt history table for Revolution Medicines (RVMD) from 2017 to 2025

Fiscal yearPeriod endedReportedTotal DebtYoYYoY change
2025$158.70M+16.8%+$22.86M
2024$135.84M+54.5%+$47.90M
2023$87.94M+37.0%+$23.74M
2022$64.20M-3.6%-$2.43M
2021$66.63M+104.0%+$33.97M
2020$32.66M+$32.66M
2019$0-100.0%-$147,000
2018$147,000+$147,000
2017$0

Total Debt values are taken from Revolution Medicines's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

In 2025, Revolution Medicines (RVMD) total debt totalled $158.70M – grew 16.8% year-over-year.

Across 2020–2025 (5 years), Revolution Medicines total debt produced a CAGR of +37.2% – with the latest reading among the more recent periods of the dataset.

The dataset's maximum total debt sits at $158.70M (2025); the minimum reading of $0 dates to 2017.

Revolution Medicines (RVMD) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.

Revolution Medicines Total Debt by Year

Revolution Medicines Total Debt 2025: $158.70M

Revolution Medicines total debt in 2025 was $158.70M, grew 16.8% from 2024. This figure represents the highest annual value in the available history.

Revolution Medicines Total Debt 2024: $135.84M

Revolution Medicines total debt in 2024 was $135.84M, surged 54.5% from 2023.

Revolution Medicines Total Debt 2023: $87.94M

Revolution Medicines total debt in 2023 was $87.94M, surged 37.0% from 2022.

Revolution Medicines Total Debt 2022: $64.20M

Revolution Medicines total debt in 2022 was $64.20M, edged down 3.6% below 2021.

Revolution Medicines Total Debt 2021: $66.63M

Revolution Medicines total debt in 2021 was $66.63M.

See more financial history for Revolution Medicines (RVMD).

Sector peers — Total Debt

Companies in the same sector as Revolution Medicines, ranked by their latest total debt.

CompanyTotal DebtSector
Novo Nordisk (NVO)$130.96BHealthcare
UnitedHealth Group (UNH)$78.39BHealthcare
AbbVie (ABBV)$69.07BHealthcare
Amgen (AMGN)$54.60BHealthcare
Merck & Co. (MRK)$50.53BHealthcare
Johnson & Johnson (JNJ)$47.93BHealthcare
Eli Lilly (LLY)$42.50BHealthcare
AstraZeneca (AZN)$29.70BHealthcare

Frequently asked questions

What is Revolution Medicines's total debt?

Latest reported total debt for Revolution Medicines (RVMD) is $156.63M (period ending March 31, 2026).

How has Revolution Medicines total debt changed year-over-year?

Revolution Medicines (RVMD) total debt changed +16.8% year-over-year on the latest annual filing.

What is the long-term growth rate of Revolution Medicines total debt?

Revolution Medicines (RVMD) total debt compound annual growth rate is +37.2% over the most recent 5 years available.

When did Revolution Medicines total debt hit its highest annual value?

Revolution Medicines total debt reached its highest annual value of $158.70M in 2025.

What was Revolution Medicines total debt in 2024?

Revolution Medicines (RVMD) total debt in 2024 was $135.84M.

What was Revolution Medicines total debt in 2025?

Revolution Medicines (RVMD) total debt in 2025 was $158.70M.

RVMD Key Financials

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.